The clinical trial ecosystem is a complex web of investigator sites, laboratories, couriers, patient samples and more. The ability to track those samples though this ecosystem with full visibility for the sponsor is essential for a successful trial. In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, describes that ecosystem and the lifecycle of patient samples.
The varying approaches of small vs. large laboratories
Risks of insufficient tracking
Tracking consent for future use
Current practice and opportunities for improved tracking
Learn more at https://www.q2labsolutions.com/labmatrix